Comment
doi: 10.1080/14653240600620044.
Cytotoxic lymphocytes for the clinic
Affiliations
- PMID: 16698682
- DOI: 10.1080/14653240600620044
Item in Clipboard
Comment
Cytotoxic lymphocytes for the clinic
Cytotherapy.
2006.
No abstract available
Comment on
-
Manufacturing of gene-modified cytotoxic T lymphocytes for autologous cellular therapy for lymphoma.Cytotherapy. 2006;8(2):105-17. doi: 10.1080/14653240600620176. Cytotherapy. 2006. PMID: 16698684
-
Type I IFN-mediated enhancement of anti-leukemic cytotoxicity of gammadelta T cells expanded from peripheral blood cells by stimulation with zoledronate.Cytotherapy. 2006;8(2):118-29. doi: 10.1080/14653240600620200. Cytotherapy. 2006. PMID: 16698685
-
Ex vivo expansion of non-MHC-restricted cytotoxic effector cells as adoptive immunotherapy for myeloma.Cytotherapy. 2006;8(2):141-8. doi: 10.1080/14653240600620218. Cytotherapy. 2006. PMID: 16698687
Similar articles
-
Identification of hematological malignancy-associated antigens and clinical applications.Rinsho Ketsueki. 2009 May;50(5):340-51. Rinsho Ketsueki. 2009. PMID: 19483393 Review. No abstract available.
-
The role of cytoplasmic granules in cytotoxicity by large granular lymphocytes and cytotoxic T lymphocytes.Adv Exp Med Biol. 1985;184:121-38. doi: 10.1007/978-1-4684-8326-0_9. Adv Exp Med Biol. 1985. PMID: 3875972 No abstract available.
-
[Cellular immunotherapy for hematological malignancies].Rinsho Ketsueki. 2008 Oct;49(10):1460-71. Rinsho Ketsueki. 2008. PMID: 18833930 Review. Japanese. No abstract available.
-
T-cell therapy: the next generation.Expert Rev Hematol. 2010 Apr;3(2):123-5. doi: 10.1586/ehm.10.10. Expert Rev Hematol. 2010. PMID: 21083454 No abstract available.
-
A little learning is a dangerous thing; especially for a cytotoxic T-lymphocyte.Rev Med Virol. 2003 Sep-Oct;13(5):275-6. doi: 10.1002/rmv.410. Rev Med Virol. 2003. PMID: 12931338 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
